Llwytho...
Recent advances in understanding idiopathic pulmonary fibrosis
Despite major research efforts leading to the recent approval of pirfenidone and nintedanib, the dismal prognosis of idiopathic pulmonary fibrosis (IPF) remains unchanged. The elaboration of international diagnostic criteria and disease stratification models based on clinical, physiological, radiolo...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | F1000Res |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
F1000Research
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4890320/ https://ncbi.nlm.nih.gov/pubmed/27303645 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.8209.1 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|